Charles Schwab’s PetMed Express PETS Stock Holding History

Charles Schwab’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,066	Closed	-$22.9K	–	3526
2026 Q1	$22.9K	Sell	10,066 -1	-0%	-$3	﹤0.01%	3451
2025 Q4	$32.2K	Buy	10,067 +67	+0.7%	+$168	﹤0.01%	3444
2025 Q3	$25.1K	Hold	10,000	–	–	﹤0.01%	3451
2025 Q2	$33.2K	Hold	10,000	–	–	﹤0.01%	3475
2025 Q1	$41.9K	Sell	10,000 -99,186	-91%	-$451K	﹤0.01%	3418
2024 Q4	$526K	Sell	109,186 -96,449	-47%	-$452K	﹤0.01%	3129
2024 Q3	$757K	Sell	205,635 -200,150	-49%	-$709K	﹤0.01%	3009
2024 Q2	$1.64M	Sell	405,785 -117,180	-22%	-$500K	﹤0.01%	2764
2024 Q1	$2.51M	Buy	522,965 +96,014	+22%	+$558K	﹤0.01%	2532
2023 Q4	$3.23M	Buy	426,951 +58,378	+16%	+$479K	﹤0.01%	2487
2023 Q3	$3.78M	Buy	368,573 +44,846	+14%	+$553K	﹤0.01%	2378
2023 Q2	$4.46M	Buy	323,727 +8,023	+3%	+$120K	﹤0.01%	2278
2023 Q1	$5.13M	Sell	315,704 -308,022	-49%	-$5.8M	﹤0.01%	2193
2022 Q4	$11M	Buy	623,726 +51,021	+9%	+$1.01M	﹤0.01%	1807
2022 Q3	$11.2M	Buy	572,705 +50,518	+10%	+$1.07M	﹤0.01%	1779
2022 Q2	$10.4M	Buy	522,187 +41,015	+9%	+$917K	﹤0.01%	1820
2022 Q1	$12.4M	Buy	481,172 +43,382	+10%	+$1.13M	﹤0.01%	1829
2021 Q4	$11.1M	Buy	437,790 +43,173	+11%	+$1.19M	﹤0.01%	1951
2021 Q3	$10.6M	Buy	394,617 +49,226	+14%	+$1.42M	﹤0.01%	1976
2021 Q2	$11M	Buy	345,391 +49,012	+17%	+$1.56M	﹤0.01%	1946
2021 Q1	$10.4M	Sell	296,379 -37,022	-11%	-$1.29M	﹤0.01%	1942
2020 Q4	$10.7M	Sell	333,401 -20,335	-6%	-$627K	﹤0.01%	1832
2020 Q3	$11.2M	Buy	353,736 +2,447	+0.7%	+$81K	0.01%	1617
2020 Q2	$12.5M	Buy	351,289 +179,527	+105%	+$6.23M	0.01%	1497
2020 Q1	$4.94M	Buy	171,762 +50,880	+42%	+$1.33M	﹤0.01%	1840
2019 Q4	$2.84M	Buy	120,882 +2,220	+2%	+$49.7K	﹤0.01%	2305
2019 Q3	$2.14M	Buy	118,662 +3,743	+3%	+$61.8K	﹤0.01%	2354
2019 Q2	$1.8M	Buy	114,919 +767	+0.7%	+$15.1K	﹤0.01%	2405
2019 Q1	$2.6M	Buy	114,152 +4,026	+4%	+$90.8K	﹤0.01%	2271
2018 Q4	$2.56M	Sell	110,126 -1,404	-1%	-$37.5K	﹤0.01%	2234
2018 Q3	$3.68M	Buy	111,530 +4,593	+4%	+$172K	﹤0.01%	2206
2018 Q2	$4.71M	Buy	106,937 +3,212	+3%	+$124K	﹤0.01%	2034
2018 Q1	$4.33M	Buy	103,725 +3,044	+3%	+$141K	﹤0.01%	2018
2017 Q4	$4.58M	Buy	100,681 +11,722	+13%	+$462K	﹤0.01%	1962
2017 Q3	$2.95M	Buy	88,959 +4,195	+5%	+$171K	﹤0.01%	2125
2017 Q2	$3.44M	Buy	84,764 +14,456	+21%	+$448K	﹤0.01%	2006
2017 Q1	$1.42M	Buy	70,308 +4,104	+6%	+$86.8K	﹤0.01%	2312
2016 Q4	$1.53M	Buy	66,204 +3,696	+6%	+$79.2K	﹤0.01%	2288
2016 Q3	$1.27M	Buy	62,508 +3,138	+5%	+$63.2K	﹤0.01%	2332
2016 Q2	$1.11M	Buy	59,370 +966	+2%	+$17.8K	﹤0.01%	2315
2016 Q1	$1.05M	Buy	58,404 +1,173	+2%	+$20.1K	﹤0.01%	2327
2015 Q4	$981K	Buy	57,231 +1,495	+3%	+$25.1K	﹤0.01%	2394
2015 Q3	$898K	Buy	55,736 +3,985	+8%	+$66.8K	﹤0.01%	2425
2015 Q2	$894K	Buy	51,751 +1,722	+3%	+$28.9K	﹤0.01%	2464
2015 Q1	$827K	Buy	50,029 +2,436	+5%	+$37.7K	﹤0.01%	2451
2014 Q4	$684K	Buy	47,593 +1,281	+3%	+$17.3K	﹤0.01%	2510
2014 Q3	$630K	Buy	46,312 +1,015	+2%	+$14.1K	﹤0.01%	2504
2014 Q2	$611K	Sell	45,297 -320	-0.7%	-$4.22K	﹤0.01%	2542
2014 Q1	$612K	Buy	45,617 +1,200	+3%	+$16.6K	﹤0.01%	2510
2013 Q4	$739K	Buy	44,417 +1,440	+3%	+$22.5K	﹤0.01%	2416
2013 Q3	$729K	Sell	42,977 -122	-0.3%	-$1.9K	﹤0.01%	2371
2013 Q2	$554K	Buy	+43,099	New	+$562K	﹤0.01%	2480

Other funds holding PETS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPH

Steel Partners Holdings New York $78M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Charles Schwab's PETS Position: Q2 2026 in Review

Charles Schwab sold out of PetMed Express (PETS) in Q2 2026, closing a stake of 10,066 shares — an estimated $22.9K sold.

Charles Schwab first reported a position in PETS in Q2 2013 and held it in 52 quarters. The position peaked at $12.5M in Q2 2020. 50 funds tracked by Wall St. Rank hold PETS as of Q2 2026.

Charles Schwab reported no remaining PetMed Express position as of Q2 2026 after selling out during the quarter.
Charles Schwab sold 10,066 PetMed Express shares in Q2 2026, an estimated $22.9K.
Charles Schwab first reported a position in PetMed Express in Q2 2013 and held it in 52 quarters.
Charles Schwab's PetMed Express position peaked at $12.5M in Q2 2020.
50 funds tracked by Wall St. Rank held PetMed Express as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.